Paydirt
RJ
Insider

Roger Jeffs

Director

Roger Jeffs (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $4.6M of LQDA (75,000 sh across 3 lots, as filed), executed May 21.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$31.7M
shares × price, as filed
Last traded
Jul 13
Filed Jul 14

Median ADV $143.6M across their filed names

Open performance
Volume by month
$20.2M$10.1M$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2025 · sells $263KApr 2025 · sells $192KJun 2025 · sells $519KJul 2025 · sells $578KAug 2025 · sells $11.7MSep 2025 · sells $1.7MOct 2025 · sells $474KJan 2026 · sells $2.5MApr 2026 · sells $6.0MMay 2026 · sells $20.2MJul 2026 · sells $2.5M
Buys $0 Sells $46.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 13 filings

Sector per market data · by filing · past 12 months

Most traded names
LQDA Liquidia Corporation LQDA · 0 buys · 18 sells 18 filings AXSM Axsome Therapeutics, Inc. AXSM · 0 buys · 3 sells 3 filings
Recent filings
LQDASALE Liquidia Corporation View filing → $2.1M
53,300 sh across 3 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET
LQDASALE Liquidia Corporation View filing → $2.1M
54,177 sh across 2 lots
Exec Apr 10
Filed Apr 14 · 5:30 PM ET
LQDASALE Liquidia Corporation View filing → $1.0M
25,000 sh × $40.12
Exec Apr 9
Filed Apr 13 · 5:30 PM ET
LQDASALE Liquidia Corporation View filing → $2.5M
66,610 sh × $37.43
Exec Jan 12
Filed Jan 13 · 5:30 PM ET
LQDASALE Liquidia Corporation View filing → $474K
20,261 sh × $23.41
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET
AXSMSALE Axsome Therapeutics, Inc. View filing → $1.7M
13,464 sh × $123.68
Exec Sep 2 2025
Filed Sep 2 2025 · 5:30 PM ET
AXSMSALE Axsome Therapeutics, Inc. View filing → $7.3M
60,000 sh across 3 lots
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET
AXSMSALE Axsome Therapeutics, Inc. View filing → $4.4M
36,694 sh across 2 lots
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET
More filings →